Market Cap (In TWD)
1.16 Billion
Revenue (In TWD)
-
Net Income (In TWD)
-92.11 Million
Avg. Volume
39.05 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 16.4-30.0
- PE
- -
- EPS
- -
- Beta Value
- 0.693
- ISIN
- TW0006709009
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Yu-Shen Hsu
- Employee Count
- -
- Website
- https://www.advagene.com.tw
- Ipo Date
- 2018-11-29
- Details
- Advagene Biopharma Co., Ltd. engages in the research and development of vaccine technology and related products in Taiwan. Its products in development include nasal spray influenza vaccine, allergy vaccines, and COVID-19 immunotherapy. The company is based in Taipei, Taiwan.
More Stocks
-
BNIX
-
MC
-
HMIHM Inwest S.A.
HMI
-
SLP
-
MICRDMicron Solutions, Inc.
MICRD
-
OMINFRALOm Infra Limited
OMINFRAL
-
JXHLYENEOS Holdings, Inc.
JXHLY
-
ELTRElectra Limited
ELTR